Drugs & Side Effects | Depression Drugs, ADD & Depression Drugs

Paxil News

Paxil Settlement reached on GlaxoSmithKline Lawsuit

RSS News Feeds
Drugs & Pharmacuticals
Paxil
Persistent Pulmonary Hypertension
 All RSS Feeds

At a glance:

Pharmaceutical provider GlaxoSmithKline, maker of the commonly prescribed anti-depressant Paxil, reached a 13 million-dollar settlement with several state governments that purchased the drug within a six-year time period.
 
According to the governments, state-funded programs were forced to pay inflated prices for the anti-depressant, because the company was involved misconduct including patent fraud and antitrust violations, hoping to sustain a monopoly and stop generic versions of the drug from entering the pharmaceutical market.

GSK settles Paxil case with states

Philadelphia Business Journal - 3/28/2006 8:14 PM

In a settlement GlaxoSmithKline will refund $13 million to state governments that bought the company's anti-depressant drug Paxil from 1997 to 2003. State governments alleged that their various programs paid inflated prices for the firm's anti-depressant drug Paxil because GlaxoSmithKline engaged in patent fraud, antitrust violations and frivolous litigation to maintain a monopoly and block generic versions from ente
 
· Read The Full Paxil Article From Philadelphia Business Journal -->

· Read All Paxil (Paroxetine Hydrochloride) News Stories -->

Comments On Paxil News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: